Stay updated on JS002 in HeFH Patients: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the JS002 in HeFH Patients: Efficacy & Safety Clinical Trial page.

Latest updates to the JS002 in HeFH Patients: Efficacy & Safety Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the Record History.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedA new site revision (v3.4.2) was added to the history and an older funding notice (v3.4.1) was removed, indicating maintenance updates rather than changes to trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedNotice added about government funding and a page revision indicator (v3.4.1), and the previous revision indicator (v3.4.0) was removed. These changes appear administrative and do not alter trial data or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check49 days agoChange DetectedUI updates add a glossary toggle, color-coded highlights for additions and deletions, and revised revision notes (Revision: v3.4.0) including No FEAR Act Data.SummaryDifference1%

- Check64 days agoChange DetectedRevision v3.3.4 was added and v3.3.3 removed in the Record History, a minor UI update to the history list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded a new revision entry (Revision: v3.3.3) to the record history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.2%

Stay in the know with updates to JS002 in HeFH Patients: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JS002 in HeFH Patients: Efficacy & Safety Clinical Trial page.